SXTP
60 Degrees Pharmaceuticals, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.77M
P/E Ratio
—
EPS
$-11.73
Beta
3.28
52W High
$17.68
52W Low
$1.29
50-Day MA
$2.94
200-Day MA
$4.69
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About 60 Degrees Pharmaceuticals, Inc. Common Stock
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company is headquartered in Washington, District of Columbia.
Fundamentals
| Revenue (TTM) | $1.41M |
| Gross Profit (TTM) | 627,400 |
| EBITDA | $-7.68M |
| Operating Margin | -606.00% |
| Return on Equity | -200.90% |
| Return on Assets | -87.20% |
| Revenue/Share (TTM) | $2.10 |
| Book Value | $-5.25 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 3.39 |
| EV/Revenue | 12.72 |
| EV/EBITDA | 22.23 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 16.20% |
| Shares Outstanding | $2.64M |
| Float | $2.60M |
| % Insiders | 1.00% |
| % Institutions | 2.73% |
Analyst Ratings
Consensus ($17.60 target)
2
BuyData last updated: 4/9/2026